Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Comment by scroll4factson Apr 02, 2016 4:32pm
169 Views
Post# 24724138

RE:RE:Bigzig said ....

RE:RE:Bigzig said ....I still believe that P2 is a significantly superior product than ordinary topical NSAIDs and that its branding and marketing (higher price) should be done accordingly.  Those are, in my opinion,  some of the greater characteristics of P2:

-  It's easier to apply with a convenient metered dose dipenser.
-  It's the only twice a day topical NSAID in the U.S.
-  It includes a powerful penetrating agent (DMSO) for enhanced efficacy.
-  It's patented (no generic)
-  has positive results from the ankle sprain trial (possible broader claims)


Bullboard Posts